Source: https://scialert.net/eboardlivedna.php?issn=1811-7775&id=91.1381
Timestamp: 2019-04-24 02:34:11+00:00

Document:
Bala, R., D. Khanna, S. Mehan and S. Kalra, 2015. Experimental evidence for the potential of Lycopene in the management of scopolamine induced amnesia. RSC Adv., 5: 72881-72892.
Bansal, N., S. Mehan, S. Kalra and D. Khanna, 2013. Boswellia serrata-frankincense (A Jesus Gifted Herb): An updated pharmacological profile. Pharmacologia, 4: 457-463.
Beniwal, L., D. Khanna and S. Mehan, 2013. Spices, Fruits, Nuts and vitamins: Preventive interventions for myocardial infarction. Pharmacologia, 4: 553-570.
Deshmukh, R., V. Sharma, S. Mehan, N. Sharma and K.L. Bedi, 2009. Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine: A PDE1 inhibitor. Eur. J. Pharmacol., 620: 49-56.
Gagandeep, B.S., Y. Sharma, R. Ahlawat, S. Rani and S. Mehan, 2014. Evaluate adaptogenic activity of fruits of Lagenaria siceraria by animal models. Int. J. Recent. Adv. Pharm. Res., 4: 85-101.
Gupta, A., V. Sehgal and S. Mehan, 2011. Hyperlipidemia: An updated review. Int. J. Biopharm. Toxicol. Res., 1: 81-89.
Heer, H. and S. Mehan, 2013. Cellular signals like MAPK/NF-κB/m-TOR mediated drug resistance: A promising concept in cancer research. Pharmacologia, 4: 414-427.
Kaur, G., S. Mehan and D. Khanna, 2015. Pharmacotherapeutic strategies associated with blood brain barrier to prevent brain tumors. Int. J. Recent Adv. Pharm. Edu Res., 5: 51-86.
Kaur, G., U. Kukkar and S. Mehan, 2016. Ameliorative strategies of natural adenyl cyclase activator to restore the mitochondrial dysfunction against 6-ohda induced Parkinson's type neurodegenerative disorders. IJPPR, 6: 21-30.
Kaur, R., S. Mehan, D. Khanna and S. Kalra, 2015. Ameliorative treatment with ellagic acid in scopolamine induced alzheimer's type memory and cognitive dysfunctions in rats. Austin J. Clin. Neurol., 2: 1-11.
Kaur, R., S. Mehan, D. Khanna and S. Kalra, 2015. Polyphenol ellagic acid-targeting to brain: A hidden treasure. Int. J. Neurol. Res., 1: 141-152.
Kaur, R., S. Mehan, S. Parveen, D. Khanna and S. Kalra, 2015. Precautionary ellagic acid treatment ameliorates chronically administered scopolamine induced alzheimer's type memory and cognitive dysfunctions in rats. Pharmacologia, 6: 192-212.
Kaur, R., S. Parveen, S. Mehan, D. Khanna and S. Kalra, 2015. Neuroprotective effect of ellagic acid against chronically scopolamine induced Alzheimer’s type memory and cognitive dysfunctions: Possible behavioural and biochemical evidences. Int. J. Preven. Med. Res, 1: 45-64.
Mehan, S., A. Verma, K.L. Bedi, V. Sehgal, A. Gupta, H. Meena and D. Sharma, 2011. Effect of mitogen activated protein kinase inhibitor in animal model of Alzheimer's disease. Int. J. Pharm. Prof. Res., 1: 212-223.
Mehan, S., D. Mishra, R. Sankhla and M. Singh, 2010. p38 MAPK kinase at the crossroads of Alzheimer`s disease. Int. J. Pharm. Prof. Res., 1: 52-60.
Mehan, S., G. Sharma, S. Kumar, M. George and L. Joseph et al., 2011. Evaluation of the antipyretic and analgesic activity of aqueous & chloroform extract of Phyllostachys bambusoides leaves. Int. J. Pharm. Prof. Res., 2: 355-358.
Mehan, S., H. Meena, D. Sharma and R. Sankhla, 2011. JNK: A stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities. J. Mol. Neurosci., 43: 376-390.
Mehan, S., R. Arora, D. Sharma, H. Meena, G. Sharma and T. Vyas, 2011. Dementia: A complete literature review on various mechanisms involves in pathogenesis and an intracerebroventricular streptozotocin induced Alzheimer's disease. Int. J. Pharm. Prof. Res., 2: 406-421.
Mehan, S., R. Arora, V. Sehgal, G. Sharma, S. Singh and S. Kawal, 2011. Effect of Salvia officinalis L. (Sage) leaves in intracerebroventricular streptozotocin (ICV-STZ) induced Alzheimer's type dementia. Int. J. Bio. Tox. Res., 1: 90-107.
Mehan, S., V.S. Nain, H. Meena, D. Sharma, R. Sankhla and M. Singh, 2010. Comparative effect of phosphodiesterase inhibitors on intracerebroventricular colchicine model of memory impairments in rats. Int. J. Pharm. Prof. Res., 1: 122-136.
Nain, V.S., S. Nain, S. Mehan, J. Panu, R.R.D. Budhiraja, 2010. Apocynin supplementation: Comparison of thermal perception and oxidative stress in diabetic induced neuropathy. Int. J. Pharm. Prof. Res., 1: 114-121.
Paliwal, Y.K., S. Mehan and P.L. Sharma, 2013. Heme oxygenase-1: A magic stick for diabetes and renal disorders. Int. J. Recent Adv. Pharm. Res., 4: 9-22.
Paliwal, Y.K., S. Mehan, K.R.V. Bijjem and P.L. Sharma, 2014. Renoprotective effect of ace Inhibitor -lisinopril and heme Oxygenase-1 Inducer-hemin combination against streptozotocin induced advanced diabetic nephropathy in rats. Pharmacologia, 5: 60-75.
Parveen, S., S. Mehan, G. Kaur and U. Kukkar, 2015. Therapeutic potential of nature molecule forskolin mediated cyclic AMP/CREB activation for the amelioration of neurodegenerative disorder like huntington's. Int. J. Rec. Adv. Pharm. Res., 5: 296-301.
Prajapat, A., V. Dave, R. Moyra, S. Mehan, G. Lal and P. Joshi, 2011. A review on effectiveness of herbal drugs in AIDS. Int. J. Biopharma Toxicol. Res., 1: 115-136.
Sharma, G., S. Kumar, N. Sharma and S. Mehan, 2011. An updated review on multiple sclerosis. Asian J. Biopharm. Pharm. Res., 3: 415-428.
Sharma, R., S. Mehan, S. Kalra and D. Khanna, 2013. Tephrosia purpurea-A magical herb with blessings in human biological system. Int. J. Recent. Adv. Pharm. Res., 3: 12-22.
Thakur, T., S. Mehan, R. Kaur and S. Kalra, 2014. Huntington's disease: A hard nut to break. Int. J. Recent Adv. Pharm. Res., 4: 38-58.
Tiwari, M., S. Mehan, M.P. Singh, H. Meena, K. Jangid and A. Deora, 2011. Neuroinflammatory mechanisms of cytokines in multiple sclerosis. Int. J. Pharm. Prof. Res., 2: 359-372.
Verma, L., M. Sakir, N. Singh, R.M. Gilhotra and S. Mehan, 2010. Development of phase change solutions for ophthalmic drug delivery based on ion activated and pH induced polymers. Int. J. Pharm. Prof. Res., 1: 137-144.
Vyas, T., S. Mehan, V. Sehgal, V. Dave and A. Prajapat et al., 2011. Alzheimer's-A neurodegenerative disease: Start to end. Int. J. Pharm. Prof. Res., 2: 422-434.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.